Envestnet Asset Management Inc Collegium Pharmaceutical, Inc Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 30,892 shares of COLL stock, worth $911,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,892

Previous 24,338 26.93%

Holding current value

$911,314

Previous $697,000 32.28%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$28.04 - $33.91 $183,774 - $222,246	6,554 Added 26.93%	30,892 $922,000
Q4 2024 Feb 12, 2025	BUY	$28.61 - $41.86 $4,348 - $6,362	152 Added 0.63%	24,338 $697,000
Q3 2024 Nov 06, 2024	BUY	$31.4 - $39.07 $115,928 - $144,246	3,692 Added 18.02%	24,186 $934,000
Q2 2024 Aug 08, 2024	BUY	$31.36 - $39.99 $108,662 - $138,565	3,465 Added 20.35%	20,494 $659,000
Q1 2024 May 13, 2024	SELL	$31.23 - $40.91 $92,159 - $120,725	-2,951 Reduced 14.77%	17,029 $661,000
Q4 2023 Feb 13, 2024	BUY	$21.16 - $30.8 $42,743 - $62,216	2,020 Added 11.25%	19,980 $614,000
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $44,986 - $51,449	2,119 Added 13.38%	17,960 $401,000
Q2 2023 Aug 04, 2023	SELL	$21.06 - $24.0 $25,651 - $29,232	-1,218 Reduced 7.14%	15,841 $340,000
Q1 2023 May 11, 2023	SELL	$23.0 - $29.88 $14,122 - $18,346	-614 Reduced 3.47%	17,059 $409,000
Q4 2022 Feb 07, 2023	SELL	$16.14 - $23.55 $451 - $659	-28 Reduced 0.16%	17,673 $410,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $24,720 - $32,139	1,599 Added 9.93%	17,701 $284,000
Q2 2022 Aug 03, 2022	BUY	$14.22 - $20.88 $1,052 - $1,545	74 Added 0.46%	16,102 $285,000
Q1 2022 May 04, 2022	BUY	$17.2 - $22.5 $52,597 - $68,805	3,058 Added 23.58%	16,028 $326,000
Q4 2021 Feb 04, 2022	SELL	$17.5 - $21.35 $75,950 - $92,659	-4,340 Reduced 25.07%	12,970 $242,000
Q3 2021 Oct 07, 2021	BUY	$17.75 - $25.39 $46,700 - $66,801	2,631 Added 17.92%	17,310 $342,000
Q2 2021 Aug 04, 2021	BUY	$21.74 - $25.28 $13,500 - $15,698	621 Added 4.42%	14,679 $347,000
Q1 2021 May 04, 2021	SELL	$19.25 - $26.1 $4,966 - $6,733	-258 Reduced 1.8%	14,058 $333,000
Q4 2020 Feb 02, 2021	BUY	$17.83 - $22.29 $58,642 - $73,311	3,289 Added 29.83%	14,316 $287,000
Q3 2020 Oct 09, 2020	BUY	$15.78 - $20.82 $2,729 - $3,601	173 Added 1.59%	11,027 $230,000
Q2 2020 Jul 08, 2020	BUY	$15.49 - $23.51 $9,758 - $14,811	630 Added 6.16%	10,854 $190,000
Q1 2020 Apr 23, 2020	BUY	$13.89 - $25.45 $142,011 - $260,200	10,224 New	10,224 $167,000

Others Institutions Holding COLL

# of Institutions

254

Shares Held

37.2M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Collegium Pharmaceutical, Inc Transaction History